Related Experiment Video
Updated: Jul 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
What's the optimal duration of anticoagulation in patients with left ventricular thrombus?
Fang Qin Goh1, Ching-Hui Sia2,3, Mark Y Chan2,3
1Department of Medicine, National University Hospital, National University Health System, Singapore.
Insights
The optimal duration for anticoagulation therapy in left ventricular thrombus (LVT) remains unclear. Further research is needed to guide treatment decisions and minimize risks of stroke or bleeding.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Thrombosis Management
Background:
- Left ventricular thrombus (LVT) is a complication of myocardial infarction and cardiomyopathies, posing a risk for embolic stroke.
- Current guidelines recommend 3-6 months of anticoagulation for LVT, but evidence is limited.
- The optimal duration is debated due to risks of bleeding with prolonged therapy and embolism with premature cessation.
Purpose of the Study:
- To review current recommendations and expert opinions on anticoagulation duration for LVT.
- To highlight the role of cardiac magnetic resonance imaging (CMR) in guiding treatment decisions.
- To identify areas for future research in LVT management.
Main Methods:
- Review of existing guidelines and expert consensus statements.
- Discussion of the diagnostic utility of echocardiography versus CMR for LVT detection.
- Analysis of factors influencing decisions for prolonged anticoagulation.
Main Results:
- No randomized trials exist for LVT anticoagulation duration.
- Expert consensus suggests 3-6 months of anticoagulation, with cessation upon thrombus resolution.
- CMR is more sensitive than echocardiography for LVT and may guide surveillance.
- Prolonged anticoagulation may be considered for persistent, mobile, or protuberant LVT, or in patients with impaired LV function.
Conclusions:
- Cardiac magnetic resonance imaging (CMR) is emerging as a key tool for LVT surveillance to guide anticoagulation.
- Further research is essential to determine the benefits of prolonged anticoagulation in specific LVT patient subgroups.
- Personalized treatment strategies are needed to balance embolic risk and bleeding complications.
Introduction:
Left ventricular thrombus (LVT) occurs in acute myocardial infarction and in ischemic and non-ischemic cardiomyopathies. LVT may result in embolic stroke. Currently, the duration of anticoagulation for LVT is unclear. This is an important clinical question as prolonged anticoagulation is associated with increased bleeding risks, while premature discontinuation may result in embolic complications.
Areas Covered:
There are no randomized trial data regarding anticoagulation duration for LVT. Guidelines and expert consensus recommend anticoagulation for 3-6 months with cessation of anticoagulation if interval imaging demonstrates thrombus resolution. Cardiac magnetic resonance imaging (CMR) is more sensitive and specific compared to echocardiography for LVT detection, and may be appropriate for high-risk patients. Prolonged anticoagulation may be considered in unresolved protuberant or mobile LVT, and in patients with resolved LVT but persistent depressed left ventricular ejection fraction and/or myocardial akinesia or dyskinesia.
Expert Opinion:
CMR will likely be increasingly used for LVT surveillance to guide anticoagulation duration. Further research is needed to determine which patients with persistent LVT on CMR benefit from prolonged anticoagulation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care

